Patología molecular en neoplasias linfoides
Publicaciones destacadas
-
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J;(...)López-Otín C; Salaverria I; Puente XS; Campo E; Beà S .Referencia:Blood 2019.
-
Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neosplasms.
Albero R; Enjuanes A; Demajo S; Castellano G; Pinyol M;(...)Colomer D; Beà S; Martin-Subero JI; Campo E; Jares P .Referencia:Journal Of Clinical Investigation 2018.
-
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina;(...)Rosenwald, Andreas; Scott, David W.; Rimsza, Lisa M.; Bea, Silvia; Campo, Elias;.Referencia:Blood 2018.
-
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
Beekman R; Chapaprieta V; Russiñol N; Vilarrasa-Blasi R; Verdaguer-Dot N;(...)López-Otín C; Gut I; Stunnenberg HG; Campo E; Martin-Subero JI .Referencia:Nature Medicine 2018.
-
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
Karube, K.; Enjuanes, A.; Dlouhy, I.; Jares, P.; Martin-Garcia, D.;(...)Schmitz, R.; Staudt, L. M.; Salaverria, I.; Lopez-Guillermo, A.; Campo, E.;.Referencia:Leukemia 2018.
-
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow S.H.; Campo E.; Pileri S.A.; Lee Harris N.; Stein H.;(...)Advani R.; Ghielmini M.; Salles G.A.; Zelenetz A.D.; Jaffe E.S..Referencia:Blood 2016.
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Bea, Silvia; Navarro, Alba; Salaverria, Itziar; Martin-Garcia, David; Jares, Pedro;(...)Hernandez, Luis; Rozman, Maria; Colomer, Dolors; Lopez-Guillermo, Armando; Campo, Elias.Referencia:Proceedings Of The National Academy Of Sciences Of The United States Of America 2013.